From the official registers: KBO 1 annual account at the National Bank publications in the Belgian Official Gazette
Summary
Neurologie AZORG has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €4,000. Its solvency ranks better than 21% of 271 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Overview
Official details
KBO- Status
- Active since 01-07-2025 Normal situation
- Registered office
- 62 active companies are registered at this address 3 started in the 12 months before. Source: KBO register, as of 1 November 2026.
- Activity
- Other research and development on natural sciences NACE 72109and 4 others
- Establishment unit
- 2.378.049.327 9300 Aalst, since 01-07-2025
- Financial year end
- 31 December
- Peppol
- Reachable since 16-07-2026
Board and ownership
- DOKTER MICHIEL MARCHAU EN DOKTER VÉRONIQUE JACOBSManaging director
- DR. DE CLERCK MATTI, NEUROLOGIEManaging director
- DR. EVA VERHELLEN, NEUROLOGIEManaging director
- DR. ILSE A. PEETERS BVManaging director
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.3%
- Gross margin
- €399
- Turnover
- ≈ €2,700
- estimated
- Equity
- €4,000
- Total assets
- €759,097
Signalsraises riskLiquidity: current ratio 1.09, cash €4,008Equity €4,000 (0.5% of total assets)Weak solvency compared with the sectorYoung companylowers riskSize: total assets €759,097Sector: Scientific research and development (NACE 72)neutralLatest accounts filed on timeShow the evidence
Bankruptcy probability
About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Searched, nothing found (1)
Comparable companies
These companies have the same main activity as Neurologie AZORG: other research and development on natural sciences (NACE 72109). They are comparable in size and age: total assets between €334,000 and €1.4m, founded between 2024 and 2025.
| Company | Total assets | Gross margin |
|---|---|---|
| Neurologie AZORG Aalst | €0.8m | €399 |
| Gynaia Belgium Leuven | €1.0m | -€0.5m |
| BLUE ARMOR Neupré | €0.5m | -€0.02m |
| SLR Belgium Brussel | €1.4m | -€0.01m |
| Arthro ID Antwerpen | €1.0m | -€0.5m |
| AUTONOMYCS Asse | €0.4m | -€0.04m |
| Stabilogreen Liège | €0.3m | -€0.03m |
Documents
Annual accounts at the NBB
- Annual accounts 2025filed on 27-07-2026
Acts in the Belgian Official Gazette
- Incorporationact of 03-07-2025
Articles and registers
- Coordinated articles of associationnotaries' database
- Entry in the KBO registerKBO Public Search
Key facts about Neurologie AZORG
- What is the company number of Neurologie AZORG?
- The company number of Neurologie AZORG is 1024.946.243. The VAT number is the same number with BE in front: BE 1024.946.243.
- Where is Neurologie AZORG based?
- The registered office is at Merestraat 80, 9300 Aalst.Company details
- What does Neurologie AZORG do?
- According to the KBO register, the main activity is other research and development on natural sciences (NACE 72109).
- What is the legal form of Neurologie AZORG?
- The legal form of Neurologie AZORG is Private limited company (BV).
- When was Neurologie AZORG founded?
- Neurologie AZORG was founded on 01-07-2025.
- Is Neurologie AZORG still active?
- Yes, Neurologie AZORG is an active enterprise in the KBO register.
- What is the turnover of Neurologie AZORG?
- The turnover in financial year 2025 is ≈ €2,700. This figure is estimated from the gross margin of €399 and 2,694 comparable companies of the same size. It probably lies between €1,100 and €6,700. It is a rough estimate.Financials
- Where can I find the annual accounts of Neurologie AZORG?
- Neurologie AZORG filed 1 annual account with the National Bank of Belgium, for financial year 2025.Annual accounts at the National Bank
Next steps
See how customers, suppliers and banks see your own company and what to improve first.